Crescendo Website

by Olivia Beke

Crescendo extend free speech licences for nhs by a month

Speech Recognition across the NHS - Provided free for 2 months

Over the past few months Crescendo has provided hundreds of Medical Speech Recognition licences to NHS organisations free of charge for 2 months, saving clinicians hours every day on typing, hours needed for additional COVID-19 tasks.

Following much positive feedback from users, all with the same message that this software has helped them clear backlogs ready for increased pressure, we have decided to extend this offer for new users who haven’t gotten a chance to sign up during the initial period due to being too busy.

Medical Speech Recognition: 

  • Saves clinics on average 1 hour a day on typing
  • Speeds up clinical letter & note production
  • Allows working from any location & shared computing
  • Free online training provided
  • Free Covid-19 Toolkit with AutoText Templates for consultations

See videos of other Clinical Systems here.

About Crescendo

Established in 1990, Crescendo is a worldwide provider of Digital Dictation, Speech Recognition and Clinical Documentation Workflow Systems within the Healthcare Market. 

With over 2,500 installations and more than 250,000 users across the UK, US, Canada, France, Germany, Australia and South Africa, Crescendo has a reputation for superior performance, commitment to quality and first class customer service.

Request your free 2-month licences
Share this offer with your colleagues
Share on email
Email
Share on whatsapp
WhatsApp
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Contact us for more information about Speech Recognition
01932 789433
uksales@crescendosystems.co.uk

*offer only available to those not already using Speech Recognition through Crescendo Systems Ltd. Offer ends 31st July 2020.

Request a quote

Start your FREE trial

Request a quote

This website uses cookies to ensure you get the best experience on our website. See our cookie policy here.